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Ferucarbotran-Enhanced Hepatic MRI at 3T Unit:
Quantitative and Qualitative Comparison of Fast Breath-
hold Imaging Sequences
Kyung Eun Cho, Jeong-Sik Yu, Jae-Joon Chung, Joo Hee Kim, Ki Whang Kim
Purpose : To compare the relative values of various fast breath-hold imaging
sequences for superparamagnetic iron-oxide (SPIO)-enhanced hepatic MRI for the
assessment of solid focal lesions with a 3T MRI unit.
Materials and Methods : 102 consecutive patients with one or more solid malignant
hepatic lesions were evaluated by spoiled gradient echo (GRE) sequences with three
different echo times (2.4 msec [GRE_2.4], 5.8 msec [GRE_5.8], and 10 msec
[GRE_10]) for T2*-weighted imaging in addition to T2-weighted turbo spin echo
(TSE) sequence following intravenous SPIO injection. Image qualities of the hepatic
contour, vascular landmarks and artifacts were rated by two independent readers
using a four-point scale. For quantitative analysis, contrast-to-noise ratio (CNR) was
measured in 170 solid focal lesions larger than 1 cm (107 hepatocellular carcinomas,
nine cholangiocarcinomas and 54 metastases).
Results : GRE_5.8 showed the highest mean points for hepatic contour, vascular
anatomy and imaging artifact presence among all of the subjected sequences
(p<0.001) and was comparable (p=0.414) with GRE_10 with regard to lesion
conspicuity. The mean CNRs were significantly higher (p<0.001) in the following
order: GRE_10 (24.4±14.5), GRE_5.8 (14.8±9.4), TSE (9.7±6.3), and GRE_2.4 (7.9
±6.4). The mean CNRs of CCCs and metastases were higher than those of HCCs for
all imaging sequences (p<0.05). 
Conclusion : Regarding overall performances, GRE using a moderate echo time of 5.8
msec can provide the most reliable data among the various fast breath-hold SPIO-
enhanced hepatic MRI sequences at 3T unit despite the lower CNR of GRE_5.8
compared to that of GRE_10.
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Introduction
In addition to the non-specific extracellular contrast
agents used in dynamic imaging, a variety of liver-
specific contrast agents have been used to assess focal
liver lesions (1). The primary role of the
superparamagnetic iron oxide (SPIO) agent, which is
taken up by Kupffer cells, is to improve the
detectability of small lesions by increasing the lesion-to-
liver contrast (1, 2). Many facilities now use high-field
magnets for body imaging, and liver MRIs using 3T
unit have become more generalized (3, 4). Compared to
the more popular and standardized 1.5T unit, high-field
unit such as the 3T MRI produce higher-resolution
imaging due to their inherently higher signal-to-noise
ratio (SNR); however, the increased instance of artifacts
produced by high-field units is a potential drawback
that can disturb imaging quality (especially in
abdominal imaging) (3-5). 
Most investigators who use 3T unit for hepatic MR
imaging follow the same parameters as those that are
used for 1.5T unit because optimal parameters have not
been specialized to the high-field magnets in SPIO-
enhanced imaging as well as in static and dynamic
imaging of the liver (4, 6, 7). Potential challenges for
better imaging quality include some changes in tissue-
specific relaxation times, precession frequencies and
susceptibility-related artifacts. The varied image quality
following SPIO injection with 3T unit shows different
consequences than that with 1.5T unit (3, 4, 6, 8). Like
the prior studies for fast imaging sequences for SPIO-
enhanced imaging in the 1.5T unit (9, 10),
determination of echo time (TE) is also essential to get
optimized T2*-weighted gradient echo images for the
detection of small focal hepatic lesions in the 3T unit.
For this purpose, image quality in terms of the
anatomic details, lesion conspicuity and imaging
artifact should be balanced with the high contrast
between the lesion and the background parenchyma
after SPIO injection (7, 10). The purpose of this study
was to evaluate the relative abilities of various fast
breath-hold imaging sequences for SPIO-enhanced
hepatic MRI for the assessment of clinically challenging
solid malignant focal lesions using a 3T unit. 
Materials and Methods
Patients
Approval for this retrospective study was obtained
from our institutional review board, which waived the
requirement of informed consent for the review of
images. We reviewed the electronic medical records of
all patients who underwent hepatic MR imaging with a
3T MRI unit during a 19-month period from July 2005
to December 2006. We identified 102 consecutive
patients (74 men and 28 women ranging from 22 to 81
years of age [mean, 55.2]) with one or more solid
malignant focal lesions verified either by
histopathologic findings or on follow-up imaging
modalities other than MRI, including digital subtraction
angiography, computed tomography (CT) and
ultrasonography, conducted 3-12 months later, as well
as with increased levels of serum tumor markers. In
patients with multiple lesions, a maximum of five
lesions of each type per patient were selected on the
basis of the aforementioned criteria; 170 total lesions
(≥ 1 cm in the longest dimension) in 102 patients were
selected for further analysis. We excluded lesions less
than 1.0 cm in length to avoid any inaccuracies in
signal intensity measurement for quantitative analysis
that could result from the partial volume averaging
effect in smaller lesions. Among the 170 lesions, we
identified 107 hepatocellular carcinomas (HCCs) in 70
patients, 54 metastases in 27 patients and nine
cholangiocarcinomas (CCCs) in five patients. For 26
HCCs, three CCCs and 41 metastases, histopathologic
verification of the lesions by means of biopsy and/or
surgery was possible. The primary sites of the
metastatic lesions included colorectal carcinoma (33
lesions in 18 patients), gastrointestinal stromal tumor
(five lesions in one patient), nasopharyngeal carcinoma
(five lesions in one patient), renal cell carcinoma (four
lesions in one patient), breast carcinoma (two lesions in
two patients), cervical cancer (two lesions in one
patient), pancreatic carcinoma (one lesion in one
patient), common bile duct cancer (one lesion in one
patient), and thyroid cancer (one lesion in one patient). 
MRI Techniques
MR imaging was performed with a 3T unit (Signa
EXCITE; GE Medical Systems, Milwaukee, WI, USA).
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Patients were positioned supine with anterior and
posterior phased-array coils centered over the liver.
After obtaining localizer images, chemical selective fat-
suppressed T2-weighted turbo spin-echo images
(TR/TE, 4000/98 msec; echo train length, 14) were
obtained in the axial plane. After obtaining a double-
echo chemical shift gradient-echo sequence (TR/first-
echo TE, second-echo TE, 160/2.4 [in-phase], 5.8
[opposed-phase]; flip angle, 70�; matrix, 352 × 300;
slice thickness, 8 mm; interslice gap, 1.5 mm), dynamic
contrast-enhanced imaging was obtained using a 3D
gradient echo (GRE) sequence (LAVA; GE Medical
Systems) with ultrafast image reconstruction using
parallel imaging algorithms (ASSET factor, 2) in the
axial plane (TR/TE, 3.5-4.2/1.0-1.2 msec; flip angle,
10�; matrix, 320 × 256; slice thickness, 5 mm; slice
spacing, 2.5 mm; number of slices, 64) during a 16-sec
breath-holding period. A dynamic series consisted of
one precontrast series followed by three postcontrast
series, including arterial, portal and five-minute
delayed phase imaging. The postcontrast series were
performed after administrating a bolus injection of
gadopentetate dimeglumine (0.1 mmol/kg of Magnevist;
Schering, Berlin, Germany) at a rate of 2 mL/sec
followed by a saline flush using a power injector. 
After the dynamic imaging, SPIO (8 μmol iron/kg of
Resovist; Schering, Berlin, Germany) was intravenously
administrated as the second contrast agent. After ten
minutes, T2-weighted turbo spin-echo (TSE) and T1-
weighted double echo chemical shift gradient-echo
(GRE) images were obtained using the same parameters
as those of the pre-contrast imaging. A GRE sequence
with a longer echo time (TR/TE, 134/10 msec; flip angle,
35�) was added for T2*-weighted imaging. All scans
were sent to the Picture Archiving and Communication
System (PACS) for interpretation on PACS workstations.
Image Analysis
For all patients, three GRE sequences, including the
two sequences of double echo techniques (TE, 2.4 msec
[GRE_2.4]; 5.8 msec [GRE_5.8]) and another GRE using
a longer TE of 10 msec for T2*-weighted imaging
[GRE_10], were subjected to comparative analyses of
SPIO-enhanced images, along with one fat-suppressed
T2-weighted TSE sequence. The images were analyzed
independently by one attending radiologist with 14
years of experience with hepatic MRIs and also by a
senior resident in the department of radiology on a
workstation (Centricity, GE Healthcare) using standard
software. After finishing the review session, evaluation
disagreements were resolved by consensus.
Qualitative image analysis was performed to identify
the sharpness of hepatic contours, the visibility of
intrahepatic vasculature and the presence of artifacts.
To ensure rating consistency, the two readers had been
previously trained in the rating of participants. The
observers recorded the hepatic contours and vascular
landmarks in each image set based on the following
four-point scale for both the right and left lobes of the
liver: 1, not visualized; 2, poorly visualized; 3,
definitely visualized; 4, sharply visualized. We assessed
the artifacts, including motion, vascular pulsation,
chemical shift, and susceptibility artifacts, on a four-
point scale using the following scores: 1, severe; 2,
moderate; 3, mild; 4, absent. For all 170 lesions, the
conspicuity of each lesion on each image set was also
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Table 1. Qualitative Assessment Based on Image Degradation Due to Artifacts 
MRI pulse Hepatic Contour Vascular Landmark Artifact Lesion Conspicuity
sequence Ranka Meanb Ranka Meanb Ranka Meanb Ranka Meanb
TSE 4 2.67 4 1.90 4 2.46 4 2.65
GRE_2.4 2 3.47 2 3.65 2 3.65 3 2.74
GRE_5.8 1 3.65 1 3.79 1 3.68 1 3.30
GRE_10 3 3.12 3 3.16 3 2.73 2 3.09
a Data indicate the rank order of image quality.
b Data are based on reader’s score of degree of image degradation (1 = severe, 2 = moderate, 3 = mild, 4 = absent).
TSE : turbo spin echo
GRE_2.4 : gradient echo with TE of 2.4 msec
GRE_5.8 : gradient echo with TE of 5.8 msec
GRE_10 : gradient echo with TE of 10 msec 
evaluated based on a four-point rating scale. A score of
1 indicated that the lesion was invisible; 2, poorly
defined; 3, fairly defined; 4, clearly defined. For
quantitative analysis, the contrast-to-noise ratio (CNR)
of each lesion was calculated using a spherical or oval
region of interest (ROI) measurement by the same
reviewers in conference using the following equation: 
CNR = (SIlesion - SIliver) / SDnoise, 
Where SIlesion is the signal intensity of the lesion;
SIliver is the signal intensity of the liver parenchyma;
and SDnoise is the standard deviation of the background
noise.
The statistical significances of the qualitative data for
the four pulse sequences were determined with using
Wilcoxon’s matched-pair signed rank test for multiple
comparisons. T-test was used to compare lesion-to-liver
CNRs between the HCCs and the other solid lesions in
the images with the four different pulse sequences. A
p-value of less than 0.05 was considered statistically
significant.
Results
On the four-point scales, the mean scores of




Fig. 1. A 59-year-old woman with a hepatocellular carcinoma in the cirrhotic liver. Among the four difference MRI
sequences of fast imaging after ferucarbotran injection, turbo spin-echo image (a) shows worst quality in hepatic contour,
vascular landmark and overall imaging artifact compared to gradient echo images using a TE of 2.4 msec (b) or 5.8 msec
(c). Due to the serious pulsation artifact, the small hepatocellular carcinoma (arrowheads) in left lobe of the liver is not
well defined on gradient echo imaging using a TE of 10 msec (d). 




Fig. 2. A 51-year-old man with a hepatocellular carcinoma in segment 4 of the cirrhotic liver. After ferucarbotran injection,
compared to turbo spin-echo image (a) or gradient echo image with a TE of 2.4 msec (b), gradient echo image with a TE of
5.8 msec (c) and gradient echo image with a TE of 10 msec (d) show better lesion (arrowheads) conspicuity.  
Table 2. Qualitative Assessment of Lesion Conspicuity
Lesion Conspicuity on Four Different MRI Sequences HCCs CCCs and Metastases Overall
GRE_5.8 vs GRE_10 < (p=0.696) < (p=0.305) < (p=0.386)
GRE_5.8 vs GRE_2.4 >* >* >*
GRE_5.8 vs TSE >* > (p =0.795) >*
GRE_10 vs GRE_2.4 >* >* >*
GRE_10 vs TSE >* > (p=0.380) >*
GRE_2.4 vs TSE <* <* <*
* Indicate the statistically significant difference (p<0.05) between two MRI sequences.
p Values for Comparison of the lesion conspicuity between each sequence in lesions with and without uptake of Superparamagnetic
Iron Oxide (SPIO).
TSE : turbo spin echo
GRE_2.4 : gradient echo with TE of 2.4 msec
GRE_5.8 : gradient echo with TE of 5.8 msec
GRE_10 : gradient echo with TE of 10 msec 
sharpness of hepatic contours, visibility of intrahepatic
vessels, presence of artifacts, and lesion conspicuity for
the four sequences are shown in Table 1. Regarding the
sharpness of hepatic contours, the visibility of
intrahepatic vessels, or the imaging artifacts, GRE_5.8
was significantly better than GRE_2.4 (p<0.001),
GRE_10 (p<0.001) or TSE (p<0.001) (Fig. 1).  
Overall lesion conspicuities of the GRE_5.8 and
GRE_10 were better than those of TSE and GRE_2.4
(p<0.001). For HCCs, lesion conspicuity was best on
the GRE_10 but was comparable with that of GRE_5.8
without statistical significance (p=0.696). GRE_5.8 and
GRE_10 were superior to the other two sequences with
regard to lesion conspicuity for HCCs (p<0.001) (Fig.
2). For CCCs and metastases, GRE_5.8 and GRE_10 as
well as TSE were superior to GRE_2.4 (p<0.001) (Fig.
3, Table 2). Although the lesion conspicuity for CCCs
and metastases on GRE_5.8 and GRE_10 were
generally superior to those of TSE, there was no
statistically significant difference between the two
(GRE_5.8 vs GRE_10, p=0.795; GRE_10 vs. TSE,
p=0.380) (Table 2).
For all lesions, the mean lesion-to-liver CNR was
highest at GRE_10 (mean ± SD = 19.8 ± 14.4) and
was significantly higher (p<0.001) than those at
GRE_5.8 (12.1±9.1), GRE_2.4 (6.3±6.4) or TSE (10.1
±7.7) (Table 3, Fig. 4). The CNRs at GRE_5.8 and TSE
were comparable (p=0.022) and were significantly




Fig. 3. A 51-year-old woman with a hepatic metastasis from uterine cervix cancer. After ferucarbotran injection, turbo
spin-echo image (a) shows better lesion (arrowheads) conspicuity compared to gradient echo image with a TE of 2.4 msec
(b) and comparable with gradient echo with a TE of 5.8 msec (c) and gradient echo with a TE of 10 msec (d). 
higher than that at GRE_2.4 (p<0.001). The mean
CNRs of CCCs and metastases were higher than those
of HCCs at GRE_10 (p<0.001) and TSE (p<0.001).
However, the CNRs were comparable between
GRE_2.4 (p=0.024) and GRE_5.8 (p=0.004) (Table 3).
Discussion
Compared to conventional 1.5T MRI unit,
optimization of body imaging data acquisition using a
3T unit requires an appreciation of the changes in T1
and T2 (11). At higher field strength, T1 and T2 of
normal tissues become lengthened and shortened,
respectively (3, 11, 12); however, because of the
various behaviors of relaxation times of a variety of
different tissues, the optimal parameters that affect
image contrast used in 3T imaging are still unknown
(11). A definite helpful aspect of a 3T system is its
higher SNR, but the benefit of high SNRs and CNRs
would be partially cancelled out by the more
prominent artifacts due to the susceptibility effects
proportional to the magnetic field strength (4, 8, 13).
However, the images obtained with a 3T system have
been regarded as having comparable quality, allowing
the assessment of focal liver lesions with equivalent
confidence as the images acquired using 1.5T imaging
(4, 6, 8, 11). 
Additionally, SPIO particles that have accumulated in
the Kupffer cells produce magnetic field heterogeneities
in addition to the shortenings of T2 or T2*, which lead
to signal loss or a decrease in the signal intensity of the
liver (3, 14-16). Although there is no remarkable
difference in the static imaging qualities between the
1.5T and 3T systems (6, 11), SPIO-enhanced imaging
could be greatly influenced by an increased
susceptibility effect. Regarding the scope of our present
study, we assumed that the higher SNR on 3T SPIO-
enhanced MRI can be attributed to the increased
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Table 3. Quantitative Assessment of Lesion-to-liver Contrast-to-noise Ratios
MR Imaging pulse sequence Lesion-to-liver CNR (Mean ± SD) Comparison Between 
All Lesions (n=170) HCCs (n=107) CCCs and Metastases (n=63) HCC and Other Lesions (p)
TSE 10.1±7.7 08.2±5.6 13.6±9.6 <0.001
GRE_2.4 06.3±6.4 05.4±5.7 07.9±7.3 <0.024
GRE_5.8 12.1±9.1 10.2±6.9 015.5±11.4 <0.004
GRE_10 019.8±14.4 016.4±11.7 025.7±16.9 <0.001
CNR : Contrast to noise ratio
SD : Standard deviation
TSE : turbo spin echo
GRE_2.4 : gradient echo with TE of 2.4 msec
GRE_5.8 : gradient echo with TE of 5.8 msec
GRE_10 : gradient echo with TE of 10 msec 
Fig. 4. Mean lesion-to-liver contrast-
to-noise ratio (CNR) of hepatic
lesions on four different fast MRI
sequences after ferucarbotran
injection. The y axis indicates the
mean lesion-to-liver CNR.
TSE : turbo spin echo
GRE_2.4 : gradient echo with TE of
2.4 msec
GRE_5.8 : gradient echo with TE of
5.8 msec
GRE_10 : gradient echo with TE of
10 msec
HCC : Hepatocellular carcinoma
Mets : Metastasis
CCC : Cholangiocellular carcinoma
susceptibility of a 3T system to iron particles taken up
by Kupffer cells in the liver parenchyma. Given that
most hepatic tumors do not contain Kupffer cells, a
greater signal loss of hepatic parenchyma on 3T would
result in higher lesion-to-liver contrast accompanied by
more pronounced artifacts from the adverse effects of
increased susceptibility compared to those of 1.5T
systems (4, 6).
Several studies have compared various imaging
techniques using SPIO for the evaluation of liver
tumors using either 1.5T or 3T MRI (2, 3, 4, 10, 17-23).
Aside from T2-weighted imaging with a short TE
similar to that of proton density imaging for
maintaining the lesion signal intensity at a moderately
higher degree, spoiled GRE with a long TE of about 10
msec provided a properly increased susceptibility effect
of SPIO for optimized T2*-weighted imaging with a
1.5T system (10). In the present study using a 3T
system, GRE_5.8 showed significantly better qualities
in terms of hepatic contour, vascular landmarks and
imaging artifacts compared to the remaining sequences
including GRE_10, which has been regarded as an
optimized sequence for the 1.5T system for SPIO-
enhanced imaging. For GRE_10 on a 3T system, the
accentuation of pulsation artifacts on the left lobe of the
liver and the marginal blurring of anatomic landmarks
resulting from a longer TE was more deteriorated with
the negative effect of increased susceptibility artifacts
from the higher field strength. Even though the mean
CNR was higher on GRE_10 compared to those of the
other sequences, the overall lesion conspicuity of
GRE_5.8 was comparable with that of GRE_10 in the
present study. Therefore, the results of the present
study suggest that the overall value of GRE_5.8 is
superior to that of GRE_10 for SPIO-enhanced imaging
on a 3T system. 
Because of the increased magnetization transfer
effects and the reduced local field heterogeneities by
the multiple 180。refocusing pulses, the effect of SPIO
enhancement on signal loss in normal liver tissue is
reduced in TSE images (18, 19, 24). In our present
study, TSE was significantly inferior to all GRE
sequences in the qualitative assessment. Lesion
conspicuity and mean CNRs also showed pessimistic
values with the TSE sequence. Even though it was
beyond the scope of our study, the TSE sequence can
help distinguish vessels from sub-centimeter lesions
and may contribute to the approving consequences in
the evaluation of focal liver lesions. The relatively low
signal intensities of vascular structures in TSE
sequences allow for improved conspicuity of small
lesions (25).  
Regarding the types of malignant focal lesions, the
mean lesion-to-liver CNR of HCCs was lower than that
of CCCs or metastases at all of the four SPIO-enhanced
fast MRI sequences in the present study. In spite of the
lack of information on our participants, we could
speculate that the cirrhotic background of the liver for
the HCC patients would disturb SPIO uptake in the
background parenchyma, which might result in
decreased CNR (26-28). Another possibility of the
partial SPIO uptake in some well-differentiated HCCs
might consequently decrease the lesion-to-liver CNR
(29), which cannot occur in CCCs or metastases.
This study had several limitations. First, due to the
retrospective manner of this study for the 1-cm or
larger lesions for quantitative analysis, the true number
of focal lesions could not be determined by a gold
standard procedure. Therefore, the sensitivity and
specificity of each sequence could not be calculated.
Second, all of the images were obtained using 3T unit;
direct comparison with images of 1.5T unit was not
possible to differentiate the optimized breath-holding
fast MR sequences based on the strength of the
magnet. Due to the limited hardware performance of
the early 3T unit used in this study, which was
installed in 2002, the fast T2-weighted imaging
sequence was not optimized for body imaging. The
imaging quality of TSE has been improved during
recent years with the 3T system, and the qualitative
score of TSE would be different if the same study were
to be performed with an updated system. 
In conclusion, regarding overall quantitative and
qualitative performances, GRE using a moderate echo
time of 5.8 msec would provide most reliable data
among the various fast breath-hold T2- or T2*-weighted
imaging sequences for SPIO-enhanced hepatic MR
imaging on the 3T unit despite the lower CNR
compared to that of echo time of 10 msec attributable
to fewer imaging artifacts and a comparable lesion
conspicuity.
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간의 3T 자기공명영상에서 초상자성산화철 조영증강
급속호흡정지영상기법들간의 양적 및 질적 비교평가
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목적: 간의 국소병변에 대한 3T 자기공명영상에서 초상자성산화철 조영증강영상을 얻기 위한 여러 급속호흡정지대열
들의 상대적 가치를 평가하고자 하였다.
대상 및 방법: 간의 자기공명영상을 시행하였던 환자들 중 한 개 이상의 악성 고형병소를 가진 102명의 연속으로 모
은 환자들을 대상으로 초상자성산화철 조영제의 정맥주사 후 촬영한 3종류의 각각 다른 에코시간(2.4 msec
[GRE_2.4], 5.8 msec [GRE_5.8], and 10 msec [GRE_10])을 갖는 T2* 강조 경사에코영상들과 하나의 T2
강조 고속스핀에코영상(TSE)을 비교하였다. 두 명의 관찰자가 독립적으로 간의 윤곽, 혈관지표, 인공물, 병변의 명확
도에 대해 각각 4점 스케일로 질적분석을 시행하였다. 양적분석을 위해 1 cm 이상의 크기를 갖는 170개의 병변들
(간세포암 107개, 담도암 9개, 간전이암 54개)에 대하여 대조도잡음비를 측정하였다. 
결과: GRE_5.8은 간윤곽, 혈관지표, 인공물에 대해 질적으로 가장 높은 점수를 받았으며(p < .001) 간 병변의 명확도
는 GRE_5.8과 GRE_10간에 유의한 차이가 없었다(p=.414). 전체적으로 평균 대조도잡음비는 GRE_10(24.4±
14.5), GRE_5.8(14.8±9.4), FSE(9.7±6.3), GRE_2.4(7.9±6.4)의 순으로 높았으며(p < .001), 영상기법에
상관없이담관암과전이암의평균대조도잡음비가간세포암에비해높았다(p < 0.05).  
결론: 3T 기기에서 악성 고형 간 병변의 진단을 위한 초상자성산화철 조영증강 급속 호흡정지기법들 중 5.8 msec의
중등도의 에코시간을 갖는 경사에코영상은 10 msec의 에코시간에 비해 대조도잡음비가 낮지만 전체적인 양적 및 질
적평가를종합하여볼때가장우수한영상을제공할수있다.
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